These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

85 related articles for article (PubMed ID: 22241926)

  • 21. Pediatric Diabetic Retinopathy: Updates in Prevalence, Risk Factors, Screening, and Management.
    Lin T; Gubitosi-Klug RA; Channa R; Wolf RM
    Curr Diab Rep; 2021 Dec; 21(12):56. PubMed ID: 34902076
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Diabetic retinopathy: global prevalence, major risk factors, screening practices and public health challenges: a review.
    Ting DS; Cheung GC; Wong TY
    Clin Exp Ophthalmol; 2016 May; 44(4):260-77. PubMed ID: 26716602
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Prevalence and risk factors for retinopathy in adolescents with type 1 diabetes.
    Fairchild JM; Hing SJ; Donaghue KC; Bonney MA; Fung AT; Stephens MM; Mitchell P; Howard NJ; Silink M
    Med J Aust; 1994 Jun; 160(12):757-62. PubMed ID: 8208191
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Monitoring for retinopathy in children and adolescents with type 1 diabetes.
    Danne T; Kordonouri O; Enders I; Hövener G
    Acta Paediatr Suppl; 1998 Oct; 425():35-41. PubMed ID: 9822192
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Six-year prevalence and incidence of diabetic retinopathy and cost-effectiveness of tele-ophthalmology in Manitoba.
    Kanjee R; Dookeran RI; Mathen MK; Stockl FA; Leicht R
    Can J Ophthalmol; 2017 Nov; 52 Suppl 1():S15-S18. PubMed ID: 29074007
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Canadian Ophthalmological Society evidence-based clinical practice guidelines for the management of diabetic retinopathy.
    Hooper P; Boucher MC; Cruess A; Dawson KG; Delpero W; Greve M; Kozousek V; Lam WC; Maberley DA
    Can J Ophthalmol; 2012 Apr; 47(2 Suppl):S1-30, S31-54. PubMed ID: 22632804
    [No Abstract]   [Full Text] [Related]  

  • 27. Canadian Ophthalmological Society Evidence-based Clinical Practice Guidelines for the Management of Diabetic Retinopathy - executive summary.
    ; Hooper P; Boucher MC; Cruess A; Dawson KG; Delpero W; Greve M; Kozousek V; Lam WC; Maberley DA
    Can J Ophthalmol; 2012 Apr; 47(2):91-6. PubMed ID: 22560411
    [No Abstract]   [Full Text] [Related]  

  • 28. [Diabetic retinopathy: pathogenesis and therapeutic implications].
    Pelikánová T
    Vnitr Lek; 2016; 62(7-8):620-8. PubMed ID: 27627088
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Ocular complications in young adults with insulin-dependent diabetes mellitus since childhood.
    Kokkonen J; Laatikainen L; van Dickhoff K; Miettinen R; Tuominen M; Lautala P; Salmela P
    Acta Paediatr; 1994 Mar; 83(3):273-8. PubMed ID: 8038529
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Diabetic Retinopathy in the Context of Patients with Diabetes.
    Simó-Servat O; Hernández C; Simó R
    Ophthalmic Res; 2019; 62(4):211-217. PubMed ID: 31129667
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Diabetic retinopathy in the pediatric population: Pathophysiology, screening, current and future treatments.
    Invernizzi A; Chhablani J; Viola F; Gabrielle PH; Zarranz-Ventura J; Staurenghi G
    Pharmacol Res; 2023 Feb; 188():106670. PubMed ID: 36681366
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Excerpt from the Canadian Ophthalmological Society evidence-based clinical practice guidelines for the management of diabetic retinopathy.
    Hooper P; Boucher MC; Cruess A; Dawson KG; Delpero W; Greve M; Kozousek V; Lam WC; Maberley DAL
    Can J Ophthalmol; 2017 Nov; 52 Suppl 1():S45-S74. PubMed ID: 29074014
    [No Abstract]   [Full Text] [Related]  

  • 33. Management of diabetic retinopathy.
    Ellis D; Burgess PI; Kayange P
    Malawi Med J; 2013 Dec; 25(4):116-20. PubMed ID: 24926400
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Current trends in the monitoring and treatment of diabetic retinopathy in young adults.
    Raczyńska D; Zorena K; Urban B; Zalewski D; Skorek A; Malukiewicz G; Sikorski BL
    Mediators Inflamm; 2014; 2014():492926. PubMed ID: 24688225
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Frontiers in diabetic retinal disease.
    Torm MEW; Dorweiler TF; Fickweiler W; Levine SR; Fort PE; Sun JK; Gardner TW
    J Diabetes Complications; 2023 Feb; 37(2):108386. PubMed ID: 36608490
    [TBL] [Abstract][Full Text] [Related]  

  • 36. The Growing Need to Understand Diabetic Retinopathy Outcomes in Youth.
    Sun JK
    JAMA Ophthalmol; 2022 Jan; 140(1):57-58. PubMed ID: 34854913
    [No Abstract]   [Full Text] [Related]  

  • 37. [Diabetic retinopathy].
    Muñoz Pena A; García Cardona F; Trilla Soler M
    Aten Primaria; 1990 Mar; 7(3):217-20, 222. PubMed ID: 2129682
    [No Abstract]   [Full Text] [Related]  

  • 38. Choosing preclinical study models of diabetic retinopathy: key problems for consideration.
    Mi XS; Yuan TF; Ding Y; Zhong JX; So KF
    Drug Des Devel Ther; 2014; 8():2311-9. PubMed ID: 25429204
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Management of Diabetic Retinopathy: An Overview.
    Boniuk I
    Angiology; 1980 Jul; 31(7):462-5. PubMed ID: 27614996
    [No Abstract]   [Full Text] [Related]  

  • 40. Screening interval for retinopathy in type 2 diabetes.
    Klein R
    Lancet; 2003 Jan; 361(9353):190-1. PubMed ID: 12547536
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.